Drugs trying to get the parents: There will be incentives for the European Scientific Community to develop research in the field of the orphan drugs

被引:5
作者
Benzi, G [1 ]
Ceci, A [1 ]
机构
[1] NEW DRUG & CLIN RES REGISTRY UNIT ABC, GENOA, ITALY
关键词
D O I
10.1006/phrs.1996.0111
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:89 / 93
页数:5
相关论文
共 10 条
[1]  
ASBURY C H, 1991, Journal of the American Medical Association, V265, P893, DOI 10.1001/jama.265.7.893
[2]  
*FDA OFF ORPH PROD, 1993, LIST ORPH PROD DES
[3]   A NEW LOOK AT THE RETURNS AND RISKS TO PHARMACEUTICAL RESEARCH-AND-DEVELOPMENT [J].
GRABOWSKI, H ;
VERNON, J .
MANAGEMENT SCIENCE, 1990, 36 (07) :804-821
[4]  
GRIFFIN J, 1996, SCRIP MAGAZINE 0510
[5]  
HAFFNER ME, 1991, ANNU REV PHARMACOL, V31, P603
[6]  
HANSEN RW, 1980, ISSUE SPHARM EC, P151
[7]   BACK TO THE FUTURE - BIOTECH PRODUCT SALES 1983-1993 [J].
KLAUSNER, A .
BIO-TECHNOLOGY, 1993, 11 (03) :S35-&
[8]   THE ECONOMICS OF ORPHAN DRUG POLICY IN THE US - CAN THE LEGISLATION BE IMPROVED [J].
PEABODY, JW ;
RUBY, A ;
CANNON, P .
PHARMACOECONOMICS, 1995, 8 (05) :374-384
[9]  
REAVES ND, 1996, 124 ANN M AM SOC PUB
[10]  
*US C, 1983, CQ ALM, P490